LEP and neoplasm: Undeniably, adipokines, such as leptin or resistin, promote cancer cell progression via enhancement of cell proliferation and migration, inflammation, promitogenic, and anti-apoptosis pathways, which subsequently can prompt tumor growth and metastatization [26].